MedTrace Logo

Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT

NCT00156728 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2008-11-04

No results posted yet for this study

Summary

The purpose of the study is to characterize atrial arrhythmias in patients indicated for Cardiac Resynchronization Therapy (CRT) and to monitor changes in atrial arrhythmias while CRT is provided.

Conditions

  • Congestive Heart Failure, Atrial Fibrillation

Interventions

DEVICE

Vitatron biventricular pacemaker

Sponsors & Collaborators

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Bert Albers, Ms Sc PhD · Medtronic BRC

  • Christophe Leclercq, MD PhD · Departement de Cardiologie et Maladies Vasculaires CHU Pontchaillou, Rennes, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Completion
2005-12-31

Countries

  • Czechia
  • France
  • Italy
  • Netherlands
  • Serbia
  • Slovakia
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156728 on ClinicalTrials.gov